NAMMI THERAPEUTICS Trademark

Trademark Overview

On Tuesday, February 26, 2019, a trademark application was filed for NAMMI THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NAMMI THERAPEUTICS trademark a serial number of 88317197. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2022. This trademark is owned by Nammi Therapeutics, Inc.. The NAMMI THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Clinical research in the field of immunotherapy; research and development services in the field of treatment of cancer and tumors; research and development in the field of development of pharmaceutical products
nammi therapeutics

General Information

Serial Number88317197
Word MarkNAMMI THERAPEUTICS
Filing DateTuesday, February 26, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements

Translation of Words in MarkThe English translation of the word "NAMMI" in the mark is "candy".
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesClinical research in the field of immunotherapy; research and development services in the field of treatment of cancer and tumors; research and development in the field of development of pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, March 18, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNAMMI THERAPEUTICS, INC.,
Party Type22 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLOS ANGELES, CA 90025
Party NameNAMMI OPS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressLOS ANGELES, CA 90025
Party NameNammi Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025
Party NameNammi Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025

Trademark Events

Event DateEvent Description
Monday, September 26, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, February 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 24, 2022SOU EXTENSION 5 GRANTED
Friday, February 18, 2022SOU EXTENSION 5 FILED
Thursday, February 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 18, 2022SOU TEAS EXTENSION RECEIVED
Thursday, August 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 17, 2021SOU EXTENSION 4 GRANTED
Tuesday, August 17, 2021SOU EXTENSION 4 FILED
Tuesday, August 17, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, March 31, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 3, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, February 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 18, 2021SOU EXTENSION 3 GRANTED
Thursday, February 18, 2021SOU EXTENSION 3 FILED
Thursday, February 18, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 28, 2020SOU EXTENSION 2 GRANTED
Tuesday, July 28, 2020SOU EXTENSION 2 FILED
Tuesday, July 28, 2020SOU TEAS EXTENSION RECEIVED
Thursday, February 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2020SOU EXTENSION 1 GRANTED
Tuesday, February 11, 2020SOU EXTENSION 1 FILED
Tuesday, February 11, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 20, 2019ASSIGNED TO LIE
Tuesday, May 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, May 7, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 7, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, May 7, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 7, 2019ASSIGNED TO EXAMINER
Monday, March 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 1, 2019NEW APPLICATION ENTERED

Related Keywords

therapeutics nammi development field research tumors pharmaceutical products cancer services immunotherapy clinical